Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
Did you mean: (Advate Diskus 500)?
(Advair Diskus 500)
84 results
  • Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study. [Randomized Controlled Trial]
    Int J Chron Obstruct Pulmon Dis 2018; 13:1125-1134Vogelmeier CF, Chapman KR, … Wedzicha JA
  • CONCLUSIONS: Overall, IND/GLY demonstrated consistent beneficial effects versus SFC on moderate/severe exacerbations, independent of prior exacerbation history or treatment. The efficacy of IND/GLY on exacerbation prevention was superior to SFC for exacerbations treated with antibiotics with/without systemic corticosteroids and was similar for exacerbations treated with systemic corticosteroids alone.
  • Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma. [Review]
    Clin Drug Investig 2018; 38(5):463-473Paik J, Scott LJ, Pleasants RA
  • The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry powder inhaler (MDPI) (AirDuo RespiClick®) was recently approved in the USA for twice-daily treatment of asthma in patients aged ≥ 12 years. This inhaled corticosteroid (ICS) and long-acting β2-adrenoreceptor agonist (LABA) combination treatment is available in low-, mid- and high-dosage formulations (55/14, 1…
New Search Next